Aster Capital Management »

Rapt Therapeutics shares owned by Aster Capital Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $34 1 34.00

More positions owned by Aster Capital Management

Broadcom (AVGO)
Wal-Mart Stores (WMT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
First Tr Exchange-traded Dj Internt Idx (FDN)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Comcast Corp Cl A (CMCSA)
Microsoft Corporation (MSFT)
Spdr Series Trust State Street Spd (XHB)
Mettler-Toledo International (MTD)
Iqvia Holdings (IQV)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Waters Corporation (WAT)
Globalfoundries Ordinary Shares (GFS)

View all positions for Aster Capital Management

Top funds holding Rapt Therapeutics

TCG Crossover Management
Fcpm Iii Services B.v.
OrbiMed Advisors
Rtw Investments
Foresite Capital Management VI
Siren
Vanguard Group
Frazier Life Sciences Management
Ikarian Capital
Braidwell
Soleus Capital Management
Nantahala Capital Management
Caligan Partners
State Street Corporation
Dr. Jeffrey R. Jay, M.D.

View all funds holding Rapt Therapeutics